1. US Food and Drug Administration (FDA) Breakthrough Device Designation. March 2020.
2. The British Standards Institute (BSI) Breakthrough Device Designation. April 2020.
You can access current holding and dividend information and update personal information, such as address and direct credit details, via our share registry, InvestorServe.
visit InvestorServe email InvestorServe
Contact OncoSil Medical Investor Relations to ask a question relating to an investment in OncoSil Medical.